- Current report filing (8-K)
February 16 2011 - 10:56AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
February 14,
2011
|
Shengtai
Pharmaceutical, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other
jurisdiction
of incorporation)
|
|
000-51312
(Commission
File
Number)
|
|
54-2155579
(I.R.S.
Employer
Identification
No.)
|
|
|
|
|
|
|
|
|
|
|
Changda
Road East, Development District, Changle County,
Shandong, PRC 262400
(Address
of principal executive offices) (zip code)
|
|
|
|
|
|
|
|
|
|
|
011-86-536-6295802
(Registrant’s
telephone number, including area code)
|
|
|
|
|
|
|
|
Not
Applicable.
|
|
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
CURRENT
REPORT ON FORM 8-K
SHENGTAI
PHARMACEUTICAL, INC.
TABLE
OF CONTENTS
|
|
|
Page
|
Item
8.01
|
Other
Events.
|
|
2
|
|
|
|
|
Item
9.01
|
Financial
Statements and Exhibits
|
|
2
|
On
February 14, 2011, Shengtai Pharmaceutical, Inc. issued a press release
reporting the financial results for the second quarter of fiscal 2011 ended
December 31, 2010.
A copy of
the press release is attached hereto as Exhibit 99.1.
Item
9.01
|
Financial
Statements and Exhibits.
|
(d) Exhibits.
Exhibit
No.
|
Description
|
|
|
99.1
|
Press
Release dated February 14, 2011
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date:
February 14, 2011
|
SHENGTAI
PHARMACEUTICAL, INC.
|
|
|
|
By:
/s/
Qingtai
Liu
Name:
Qingtai Liu
Title:
Chief Executive
Officer
|
Shengtai Pharmaceutical (GM) (USOTC:SGTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Shengtai Pharmaceutical (GM) (USOTC:SGTI)
Historical Stock Chart
From Sep 2023 to Sep 2024